homovanillic acid and clioquinol

homovanillic acid has been researched along with clioquinol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, JK; Beal, MF; Boonplueang, R; Bush, AI; Cherny, RA; DiMonte, D; Ellerby, L; Jacobs, R; Kaur, D; Kumar, J; Mo, JQ; Rajagopalan, S; Viswanath, V; Volitaskis, I; Yang, L; Yantiri, F	1

Other Studies

1 other study(ies) available for homovanillic acid and clioquinol

Article	Year
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron, 2003, Mar-27, Volume: 37, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Death; Clioquinol; Dopamine; Ferritins; Gene Expression; Genetic Therapy; Homovanillic Acid; Humans; Immunohistochemistry; Iron; Iron Chelating Agents; Mice; Mice, Transgenic; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Promoter Regions, Genetic; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase	2003

Article

Year

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.

Neuron, 2003, Mar-27, Volume: 37, Issue:6

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Death; Clioquinol; Dopamine; Ferritins; Gene Expression; Genetic Therapy; Homovanillic Acid; Humans; Immunohistochemistry; Iron; Iron Chelating Agents; Mice; Mice, Transgenic; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Promoter Regions, Genetic; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase

2003